Autres langues SanBio Company Limited

Actions

4592

JP3336750009

Temps Différé Japan Exchange Autres places de cotation 08:00:00 02/05/2024			Varia. 5j.	Varia. 1 janv.
430 ^JPY	+2,38 %		+3,12 %	-38,75 %

19/03	SANBIO COMPANY LIMITED : Jefferies & Co. est à vendre sur le dossier	ZM
19/03	Transcript : SanBio Company Limited, 2024 Earnings Call, Mar 19, 2024

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

SanBio Eyes Approval for Brain Injury Treatment Drug SB623 By March	19/03
SanBio Books Non-operating Income, Extraordinary Gains, Deferred Income Taxes in Fiscal 2024	19/03
SanBio's FY2024 Attributable Net Loss Narrows on Lower Costs, Forex Gains	19/03
Sanbio Company Limited Provides Consolidated Earnings Guidance for the First Half of Fiscal Year Ending January 31, 2025, and Full Fiscal Year Ending January 31, 2025	18/03
SanBio Liquidates Singapore Unit	14/02
Sanbio Co., Ltd. Provides Update on Status of Manufacturing and Marketing Approval for Sb623 Chronic Traumatic Brain Injury Program in Japan	25/01
SanBio to Cancel Certain Stock Options	10/01
SanBio Logs Extraordinary Gain from Asset Sale of US Unit	21/12
Sanbio Widens Nine-Month Attributable Net Loss	15/12
Sanbio Cuts Staff Amid Restructuring of Overseas Subsidiary	15/12
Sanbio Expects to Receive Regulatory Nod for Stem Cell Therapy Candidate in March 2024	15/12
SanBio Company Limited Provides Update on Status of Manufacturing and Marketing Approval for SB623 Chronic Traumatic Brain Injury Program in Japan	14/12
SanBio's Overseas Subsidiary to Carry Out Personnel Reduction by November	12/07/23
SanBio Co., Ltd. Updates on Status of Manufacturing and Marketing Approval for SB623 Chronic Traumatic Brain Injury Program in Japan	14/06/23
SanBio Company Limited Provides Consolidated Earnings Guidance for the First Half and Full Year Ending January 31, 2024	14/06/23
Japan Stock Market Remains Jittery Despite Damage Control; Toyota Industries Plummets 11% Over Fresh Data Scandal	20/03/23
SanBio to Wind Up Singapore Unit	20/03/23
SanBio's FY23 Loss Widens	20/03/23
Sanbio Company Limited Provides Consolidated Earnings Guidance for the First Half of Fiscal Year Ending January 31, 2024, and Full Fiscal Year Ending January 31, 2024	17/03/23
SanBio to Acquire, Cancel Over 100,000 Stock Options	23/02/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues SanBio Company Limited

Actions

4592

JP3336750009

Autres langues

Filtres